Summary
PHARMIMPULSE has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €4k. Equity remains stable across the filed fiscal years (±0% per year). Its solvency ranks better than 14% of 997 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
No current score
Insufficient figures
A score requires measurable solvency, liquidity and profitability. Missing figures are not a judgement about the company.
Axes · tick = 2022
Profitability-
Solvency26▼-1
Growth55=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 78
Relative position
BE, all sectors
reference
Sector 78
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
1%
Age of the figures
21 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 14% of 997 sector peers (2024).
NBB · sector comparisonPosition among 997 sector peers
Solvency
better than 14%
← weakest
strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 21-10-2025, 82 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 8 filingsDeviation from the deadline
2025
not confirmed
2024
82 d late
2022
147 d late
2021
31 d late
2020
61 d late
2019
91 d late
2018
27 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
Not included in this filing
Working capital
€-5k▲ 35.1%
2022 · €-7k
2018: €9k
2019: €4k
2020: €4k
2021: €-7k
2022: €-7k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20192020202120222024Trend
Equity€4k-€4k=€4k=€4k=€4k=
Operating result€359-€54▼ 85.0%€479▲ 792%€1k▲ 192%€3k▲ 144%
Result per fiscal year
Operating result
The operating result is €3k in 2024, compared with €1k in 2022. Comparable figures for the intervening years are unavailable.
Balance-sheet composition
2024 in colour, 2022 as the grey bar beneath
Assets €384k
Fixed assets
€8k ▼ 23.2%
Current assets
€376k ▲ 79.9%
Equity and liabilities €384k
Equity
€4k =
Debt
€381k ▲ 76.0%
Debt's share of the balance-sheet total rises from 98.3% to 99.0%. Debt is higher.
Key figures and ratios
EBITDA
€5k▲
2022 · €3k
Current ratio
0.99▲
2022 · 0.97
Interest coverage
1.21▼
2022 · 1.91
Debt ≤ 1 year
€381k▲
2022 · €216k
Staff costs
€838k▲
2022 · €713k
A ratio outside any meaningful range has been withheld (balance sheet total €384k, equity €4k).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2022 · 33 lines
Balance sheet
Code20222024
Assets
Total assets20/58€220k€384k▲
Fixed assets21/28€11k€8k▼
Tangible fixed assets22/27€11k€8k▼
Other tangible fixed assets26€11k€8k▼
Current assets29/58€209k€376k▲
Amounts receivable within one year40/41€185k€360k▲
Trade receivables40€182k€306k▲
Other amounts receivable41€2k€54k▲
Cash at bank and in hand54/58€24k€15k▼
Deferred charges and accrued income490/1-€818
Equity and liabilities
Total equity and liabilities10/49€220k€384k▲
Equity10/15€4k€4k=
Contributions10/11€4k€4k=
Outside capital11-€4k
Other1109/19-€4k
Amounts payable17/49€216k€381k▲
Amounts payable within one year42/48€216k€381k▲
Financial debts43-€23k
Credit institutions430/8-€23k
Trade debts44€34k€154k▲
Suppliers440/4€34k€154k▲
Taxes, remuneration and social security45€163k€117k▼
Taxes450/3€65k€38k▼
Remuneration and social security454/9€98k€79k▼
Other amounts payable47/48€19k€87k▲
Income statement
Code20222024
Remuneration, social security and pensions62€713k€838k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1k€1k=
Gross operating margin9900€716k€843k▲
Operating profit (loss)9901€1k€3k▲
Financial income75/76B-€468
Recurring financial income75-€468
Financial charges65/66B€1k€4k▲
Recurring financial charges65€1k€4k▲
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
21-10
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 82 days late
2023
25-12
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 147 days late
2022
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 31 days late
2021
30-09
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 61 days late
2020
30-10
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 91 days late
2019
27-08
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 27 days late
2018
30-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 30 days late
2017
25-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 25 days late
NBB filing
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Lasne · 1 establishment unit since 2015
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue de la Bachée 861380 LasneGround area
2,122 m²
Building footprint
109 m²
Volume, LiDAR
230 m³
Parcel 25087C0102/00R000, Wallonia · tallest building 6.7 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
PHARMIMPULSE
since 20152.245.120.824
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25087C0102/00R000 | Wallonia | 2,122 m² | 1 · 109 m² | 6.7 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
BRISON CONSTRUCT
BE 0566.978.361
Nivelles · Eq €3,931
JOBCONNECTION
BE 0475.767.776
Leuven · Eq €3,565
LXL
BE 1021.852.933
Watermaal-Bosvoorde · Eq €3,523
HOSTPITALITY
BE 1018.921.256
Maasmechelen · Eq €3,998
Swysen & Partners
BE 0791.359.652
Vorst · Eq €4,098
Of 1,014 companies in sector 78200 we hold annual accounts for 645. 150 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formGeneral partnership
Founded11-08-2015
Fiscal year end31-12
Activities, NACEBEL 2025
78200Temporary employment agencies and other provision of personnel
82100Office administrative and support services
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.